Blog

Peyronie’s disease (PD) remains one of urology’s most perplexing conditions—a connective tissue disorder characterized by fibrous scar tissue (plaque) formation within the penile tunica albuginea. This pathology manifests as penile curvature, pain, shortening, and erectile dysfunction, creating profound physical and psychological challenges. Despite centuries of medical observation since François de la Peyronie’s initial description in 1743, the precise etiology remains elusive. Current research points to a complex interplay of physical trauma, genetic predisposition, inflammatory processes, and molecular signaling abnormalities that disrupt normal wound healing in penile tissues

The Trauma Hypothesis

The most widely accepted theory suggests that repetitive microtrauma to the erect penis initiates the disease process. During vigorous sexual activity, athletic endeavors, or accidents, the penis—particularly when in a semi-rigid state—may experience buckling forces.

This causes delamination of the tunica albuginea’s bilayered structure (outer longitudinal and inner circular layers) where they merge at the midline septum. The resulting microvascular damage leads to extravasation of blood components, including fibrinogen, which converts to fibrin and creates a persistent fibrin matrix.

This theory explains why PD frequently develops in sexually active men, though intriguingly, up to 80% of patients report no specific traumatic incident. This suggests microtrauma may accumulate subtly over time or that alternative pathways exist. The trapped fibrin deposit becomes a scaffold for inflammatory cells, initiating a cascade of abnormal healing responses.

Pathophysiological Cascade

Once trauma occurs, the pathophysiology unfolds through three interconnected phases:

1. Inflammatory Phase: The fibrin matrix attracts inflammatory cells (macrophages, neutrophils, mast cells) that release cytokines and growth factors, particularly Transforming Growth Factor-beta 1 (TGF-β1). TGF-β1 is the master regulator of fibrosis, stimulating fibroblasts to transform into collagen-producing myofibroblasts and promoting the deposition of type III collagen over the normal type I found in the tunica.
2. Fibrotic Phase: Myofibroblasts (identified by α-smooth muscle actin expression) proliferate excessively and produce massive amounts of disorganized collagen and extracellular matrix (ECM) components. This disrupts the tunica albuginea’s delicate lattice of elastic fibers and collagen fibrils, replacing flexible tissue with an inelastic plaque. Crucially, an imbalance occurs between matrix metalloproteinases (MMPs) that normally degrade collagen and their inhibitors (TIMPs), favoring ECM accumulation.
3. Remodeling Phase: The plaque matures and may calcify. The inelastic scar tethers the affected area, preventing uniform expansion during erection, leading to characteristic curvature, indentation (hourglass deformity), or shortening.

Key Molecular Players in Peyronie’s Disease Pathophysiology

Genetic and Epigenetic Susceptibility

Not all men experiencing penile trauma develop PD, highlighting the critical role of inherent susceptibility. Evidence points strongly to a genetic component:

• Familial Clustering: Men with a first-degree relative affected by PD have a significantly increased risk, suggesting an autosomal dominant pattern with incomplete penetrance.
• HLA Associations: Specific human leukocyte antigen (HLA) types, particularly within the HLA-B7 cross-reactive group (e.g., HLA-B27) and class II antigens (HLA-DR3, HLA-DQw2), are more prevalent in PD patients. These HLA types are often linked to autoimmune and fibroproliferative disorders.
• Chromosomal Abnormalities: Studies report karyotypic changes (e.g., duplications of chromosome 7 and 8, deletion of chromosome Y) in fibroblasts derived from PD plaques.
• Gene Polymorphisms & Epigenetics: Polymorphisms in genes involved in inflammation and fibrosis (e.g., TGF-β1, MCP-1), overexpression of profibrotic genes like pleiotrophin (PTN/OSF-1), and epigenetic modifications such as histone deacetylation (HDACs) may predispose individuals to abnormal scarring responses.

Significant Risk Factors and Comorbidities

Beyond genetics and trauma, several factors significantly increase PD risk or influence its severity:

• Connective Tissue Disorders: A strong association exists with Dupuytren’s contracture (present in 4%-26% of PD patients), plantar fasciitis, Ledderhose disease, and scleroderma. This shared susceptibility points to a systemic fibrotic diathesis.
• Diabetes Mellitus (DM): Men with DM, especially those with ED, are 4-5 times more likely to develop PD. Poor glycemic control, longer DM duration, and diabetic microangiopathy likely contribute by impairing wound healing, decreasing tunical elasticity, and exacerbating fibrosis.
• Hypogonadism (Low Testosterone): Studies report a high prevalence (up to 74%) of low testosterone (<300 ng/dL) in PD patients, potentially linked to impaired wound healing modulation by androgens. Hypogonadal men may also experience more severe curvature.
• Age: PD peaks in men aged 50-70 years, likely due to age-related decreased tissue elasticity, reduced healing capacity, and increased prevalence of vascular comorbidities. However, cases occur from adolescence onwards, with younger patients often presenting with more plaques and potentially higher HbA1c levels.
• Urological Surgery: Procedures involving the genital tract or perineum, notably radical prostatectomy (up to 16% risk), urethral catheterization, and cystoscopy, are recognized risk factors, likely due to surgical trauma or neurovascular compromise.
• Lifestyle Factors: Smoking is consistently linked to increased PD risk, likely through microvascular damage and oxidative stress. The evidence for alcohol consumption is more conflicting.
• Vascular Comorbidities: Hypertension, dyslipidemia, and erectile dysfunction are frequently associated, suggesting underlying endothelial dysfunction and vascular compromise may contribute to the microenvironment favoring fibrosis.
• Autoimmune Conditions: Conditions like systemic lupus erythematosus (SLE) are associated with a higher PD incidence, and features of autoimmunity (e.g., anti-elastin antibodies) have been detected, suggesting immune dysregulation may play a role.

Major Risk Factors for Peyronie’s Disease

Progression: Acute vs. Chronic Phases

PD evolves through distinct clinical phases:

1. Acute (Active) Phase (6-18 months): Characterized by inflammatory pain (during erection or spontaneously), progressive penile curvature/deformity, and plaque formation. This is the window where medical interventions aimed at halting inflammation and fibrosis may be most effective.
2. Chronic (Stable) Phase: Inflammation subsides, pain typically resolves, and the plaque stabilizes, often with calcification. Curvature and shortening persist but usually do not worsen further. Erectile dysfunction becomes a more prominent concern due to the mechanical effects of the plaque and potential underlying vascular compromise. Treatment focuses on correcting deformity and managing ED.

Complications: Beyond the Physical Curve

The consequences of PD extend far beyond penile deformity:

• Erectile Dysfunction (ED): Affects 30-60% of PD patients, particularly those over 40. Plaque location can impede veno-occlusion necessary for rigid erections. Vascular factors common to both PD and ED (e.g., diabetes, smoking) often coexist, and the psychological burden further exacerbates ED.
• Penile Shortening: Significant loss of length (0.5-1.5 cm or more) is common and often a major patient concern.
• Painful Intercourse: For both the patient and partner, making vaginal intromission difficult or impossible, especially with curvatures exceeding 30 degrees 511.
• Profound Psychological Impact: Depression, anxiety, distress, shame, low self-esteem, and relationship strain are highly prevalent due to concerns over appearance, sexual function, and masculinity.

• Can Collagen Supplements Cause Peyronie’s Disease?
• Can Erectile Dysfunction Cause Peyronie’s Disease?
• Can you get Peyronie’s Disease at a young age?
• Understanding Trauma-Induced Peyronie’s Disease
• How does Xiaflex work for Peyronie’s disease?